Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Lisata Therapeutics (LSTA) Return on Equity (2016 - 2025)

Lisata Therapeutics filings provide 12 years of Return on Equity readings, the most recent being 1.03% for Q4 2025.

  • For the quarter ending Q4 2025, Return on Equity fell 39.0% year-over-year to 1.03%, compared with a TTM value of 1.03% through Dec 2025, down 39.0%, and an annual FY2025 reading of 0.75%, down 23.0% over the prior year.
  • Return on Equity hit 1.03% in Q4 2025 for Lisata Therapeutics, down from 0.96% in the prior quarter.
  • The five-year high for Return on Equity was 0.34% in Q2 2023, with the low at 1.03% in Q4 2025.
  • Median Return on Equity over the past 3 years was 0.55% (2024), compared with a mean of 0.61%.
  • The sharpest move saw Return on Equity rose 4bps in 2024, then crashed -39bps in 2025.
  • Year by year, Return on Equity stood at 0.41% in 2023, then tumbled by -53bps to 0.63% in 2024, then crashed by -62bps to 1.03% in 2025.
  • According to Business Quant data, Return on Equity over the past three periods came in at 1.03%, 0.96%, and 0.82% for Q4 2025, Q3 2025, and Q2 2025 respectively.